IRIS UniCatt

Ruggeri, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.041
NA - Nord America 2.518
AS - Asia 979
SA - Sud America 204
AF - Africa 15
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.482
IT - Italia 1.176
DE - Germania 627
SG - Singapore 368
CN - Cina 359
SE - Svezia 332
UA - Ucraina 269
BR - Brasile 186
FR - Francia 148
IE - Irlanda 115
GB - Regno Unito 101
ID - Indonesia 67
FI - Finlandia 64
RU - Federazione Russa 55
IN - India 53
TR - Turchia 43
CA - Canada 28
ES - Italia 28
NL - Olanda 28
BE - Belgio 25
CH - Svizzera 21
IR - Iran 15
PL - Polonia 12
VN - Vietnam 11
HK - Hong Kong 10
KR - Corea 9
AR - Argentina 8
JP - Giappone 8
RO - Romania 7
AU - Australia 6
EU - Europa 5
HR - Croazia 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
GR - Grecia 4
IQ - Iraq 4
KZ - Kazakistan 4
MX - Messico 4
ZA - Sudafrica 4
AT - Austria 3
BD - Bangladesh 3
JO - Giordania 3
LT - Lituania 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
MD - Moldavia 2
MZ - Mozambico 2
UZ - Uzbekistan 2
AL - Albania 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.771
Salva come PNG Salva come JPEG
Città #
Chandler 434
Jacksonville 190
Singapore 178
Milan 158
Ashburn 153
Ann Arbor 147
Plan 117
Dublin 113
San Mateo 112
Cattolica 110
Nanjing 92
Woodbridge 76
Rome 73
Wilmington 68
Bremen 67
Jakarta 67
Dearborn 59
Lawrence 57
Boston 55
Munich 47
Mountain View 46
Nanchang 42
Marseille 38
Seattle 38
Moscow 37
Beijing 29
Redwood City 27
Frattamaggiore 26
Turin 26
Houston 25
Izmir 25
Brussels 23
Shanghai 22
São Paulo 22
Los Angeles 20
Boardman 19
Frankfurt am Main 18
New York 18
Jiaxing 17
Redmond 17
Enterprise 16
Hebei 16
Lancaster 16
Kunming 15
Fairfield 14
Bari 13
Changsha 13
Hangzhou 13
Norwalk 13
Nürnberg 13
Augusta 12
Detroit 12
Torino 12
University Park 12
Bologna 11
Guangzhou 11
Falls Church 10
Fremont 10
Princeton 10
Como 9
Hong Kong 9
Kish 9
Kraków 9
Napoli 9
Ottawa 9
Chicago 8
Düsseldorf 8
Paris 8
Pune 8
Taranto 8
Tianjin 8
Florence 7
London 7
Moncalieri 7
Mumbai 7
Zurich 7
Arzano 6
Cambridge 6
Chennai 6
Getafe 6
San Jose 6
Shenyang 6
Toronto 6
Andover 5
Atlanta 5
Buccinasco 5
Campinas 5
Eboli 5
Gaziantep 5
Genoa 5
Hanoi 5
Modena 5
Palermo 5
Parma 5
Pescia 5
Rio de Janeiro 5
Salvador 5
San Francisco 5
Scicli 5
Trento 5
Totale 3.414
Salva come PNG Salva come JPEG
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 664
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 352
Economia sanitaria 183
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 175
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 142
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 137
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 134
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 133
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 131
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 127
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 122
Healthcare expenditure on prevention in the spending review era 118
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 113
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 110
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study. 107
Economic evaluation of screening programs for HCV: evidence from literature. 107
A cost effectiveness analysis of cataract surgery 107
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 106
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 104
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. 100
Between rationing and rationalization. The challenges of the Italian National Health Service during the age of the great crisis 99
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 98
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato 96
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 96
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 95
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 94
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 92
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 91
The cost-effectiveness of alternative strategies against HBV in Italy 90
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 89
Cost effectiveness analysis of transnasal fentalyl citrate in the treatment of BTcP 89
A new decision model for economic evaluation of novel therapies for HCV 89
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults 88
Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone. 86
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life. 86
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 86
The minimum clinically important difference of the EQ-5D index. 85
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 84
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 84
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 79
Normative needs in healthcare: toward a new conceptualization of equity and capabilities. 79
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica 78
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 78
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 77
Economic Assessment of an Anti-HCV Screening Program in Italy 77
New professional roles and patient satisfaction: evidence from a European survey along three clinical pathways 77
Valutazione economica di ranibizumab vs pegaptanib o vs terapia fotodinamica con verteporfina 76
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 76
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort 74
New Healthcare Professional Roles in Europe: a Survey of Patients' Experiences and Views in Nine Countries 73
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. 72
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 71
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 71
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review. 70
The cost effectiveness of Botox in Italian patients with chronic migraine. 66
Analisi economica per l’estensione della vaccinazione contro l’influenza agli individui di età 50-64: risparmi sociali e analisi di Budget Impact 63
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. 63
Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study. 63
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 63
Valutazione dei costi delle infezioni nosocomiali da E.Coli in un policlinico romano di 1700 posti letto 61
Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. 59
Setting research priorities in the feld of emergency management: which piece of information are you willing to pay more? 55
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy . 55
Introduction to essay health and economics 53
Is risk attitude really specific within the health context domain? Further evidence from an Italian survey using Probability Equivalent technique and face to face interviews 48
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review 46
Is risk outcome specific within the health domain? 40
Totale 6.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 0 0 0 0 0 0 0 73
2020/2021718 53 157 18 61 78 16 44 26 145 22 83 15
2021/2022677 58 68 20 27 31 26 54 108 30 43 84 128
2022/20231.319 147 186 96 223 91 170 56 113 163 17 46 11
2023/2024614 36 179 20 38 32 67 20 29 18 26 83 66
2024/20251.013 24 50 105 28 121 29 13 46 207 87 177 126
Totale 6.852